A computer simulation model of the cost-effectiveness of routine Staphylococcus aureus screening and decolonization among lung and heart-lung transplant recipients

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 6, 2014, Pages 1053-1061

  Clancy, C J ^a,b   Bartsch, S M ^c   Nguyen, M H ^a   Stuckey, D R ^c   Shields, R K ^a   Lee, B Y ^c,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c University of Pittsburgh   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NAFCILLIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL DECOLONIZATION; CHILD; COMPUTER SIMULATION; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG BLOOD LEVEL; FEMALE; GRAFT RECIPIENT; HEART LUNG TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RESPIRATORY TRACT INFECTION; SCREENING; SENSITIVITY ANALYSIS; STAPHYLOCOCCUS AUREUS; TRACHEOBRONCHITIS; COHORT ANALYSIS; COST BENEFIT ANALYSIS; DIAGNOSIS; DRUG THERAPY; ECONOMICS; HEART TRANSPLANTATION; HETEROZYGOTE; INFANT; ISOLATION AND PURIFICATION; LUNG TRANSPLANTATION; MASS SCREENING; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; RETROSPECTIVE STUDY; STAPHYLOCOCCAL INFECTIONS; UNITED STATES; UNIVERSITY HOSPITAL; VERY ELDERLY; YOUNG ADULT;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARRIER STATE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; FEMALE; HEART TRANSPLANTATION; HUMANS; INFANT; LUNG TRANSPLANTATION; MALE; MASS SCREENING; MIDDLE AGED; PENNSYLVANIA; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANSPLANT RECIPIENTS; YOUNG ADULT;

EID: 84903818415     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-2046-y     Document Type: Article

References (41)

1. Shields RK, Clancy CJ, Minces LR, Kwak EJ, Silveira FP, Abdel-Massih RC, Toyoda Y, Bermudez C, Bhama JK, Shigemura N, Pilewski JM, Crespo MM, Nguyen MH (2012) Staphylococcus aureus infections in the early period after lung transplantation: Epidemiology, risk factors and outcomes. J Heart Lung Transplant 31(7):700-707
2. Bode LG, Kluytmans JA,Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, Troelstra A, Box AT, Voss A, van der Tweel I, van Belkum A, Verbrugh HA, Vos MC (2010) Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 362(1):9-17
3. van Rijen M, Bonten M, Wenzel R, Kluytmans J (2008) Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev (4):CD006216
4. Wenzel RP (2010) Minimizing surgical-site infections. N Engl J Med 362(1):75-77
5. Edmond MB, Wenzel RP (2013) Screening inpatients for MRSA-case closed. N Engl J Med 368(24):2314-2315
6. Farr BM (2006)What to think if the results of the National Institutes of Health randomized trial of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus control measures are negative (and other advice to young epidemiologists): a review and an au revoir. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am 27(10):1096-1106
7. Lee BY, Song Y, McGlone SM, Bailey RR, Feura J, Tai JHY, Lewis GJ, Wiringa AE, Smith KJ, Muder RR, Harrison LH, Piraino B (2011) The economic value of screening haemodialysis patients for methicillin-resistant Staphylococcus aureus in the USA. Clin Microbiol Infect 17(11):1717-1726
8. Lee BY, Tsui BY, Bailey RR, Smith KJ,Muder RR, Lewis GJ, Harrison LH (2009) Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am 30(12):1158-1165
9. Lee BY, Wiringa AE, Bailey RR, Goyal V, Lewis GJ, Tsui BY, Smith KJ,Muder RR (2010) Screening cardiac surgery patients for MRSA: an economic computer model. Am J Managed Care 16(7):e163-e173
10. Lee BY, Wiringa AE, Bailey RR, Goyal V, Tsui B, Lewis GJ, Muder RR, Harrison LH (2010) The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am 31(11):1130-1138
11. Husain S, Mooney ML, Danziger-Isakov L, Mattner F, Singh N, Avery R, Ison M, Humar A, Padera RF, Lawler LP, Fisher A, Drew RJ, Gould KF, Sole A, Studer S, Munoz P, Singer LG, Hannan M, Definitions IIDCWGo (2011) A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients. J Heart Lung Transplant: Off Publ Int Soc Heart Transplant 30(4):361-374
12. Trulock EP, Christie JD, Edwards LB, Boucek MM, Aurora P, Taylor DO, Dobbels F, Rahmel AO, Keck BM, Hertz MI (2007) Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant: Off Publ Int Soc Heart Transplant 26(8):782-795 (Pubitemid 47199080)
13. Graves N (2004) Economics and preventing hospital-acquired infection. Emerg Infect Dis 10(4):561-566
14. Vadnerkar A, Toyoda Y, Crespo M, Pilewski J, Mitsani D, Kwak EJ, Silveira FP, Bhama J, Shields R, Bermudez C, Clancy CJ, Nguyen MH (2011) Age-specific complications among lung transplant recipients 60 years and older. J Heart Lung Transplant: Off Publ Int Soc Heart Transplant 30(3):273-281
15. Lee BY (2008) Digital decision making: computer models and antibiotic prescribing in the twenty-first century. Clin Infect Dis: Off Publ Infect Dis Soc Am 46(8):1139-1141
16. Puzniak LA, Gillespie KN, Leet T, Kollef M, Mundy LM (2004) A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price? Infect Control Hosp Epidemiol 25:418-424 (Pubitemid 38621090)
17. Centers for Medicare and Medicaid Services (2010) 2010 Clinical Diagnostic Laboratory Fee Schedule (CLAB). U.S. Department of Health & Human Services, Baltimore, MD, http://www.cms.gov/ClinicalLabFeeSched/. Cited 27 April 2010
18. Physicians Desk Reference (2010) Red Book Pharmacy's Fundamental Reference. Thompson Reuters (Healthcare), Inc, Montvale
19. American Medical Association (2011) CPT Code/Relative Value Search, https://ocm.ama-assn.org/OCM/CPTRelativeValueSearch.do. Cited 27 April 2011
20. Bureau of Labor Statistics (2011) Occupational employment statistics: May 2010 national occupational employment and wage estimates, United States. U.S. Bureau of Labor Statistics Division of Occupational Employment Statistics, Washington, D.C., Cited 20 September 2011
21. AHRQ (2009) United States Department of Health and Human Services HCUP facts and figures: statistics on hospital-based care in the United States, 2009. AHRQ: Agency for Healthcare Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/reports.jsp. Cited 11 July 2012
22. Cooke CR, Kahn JM, Watkins TR, Hudson LD, Rubenfeld GD (2009) Cost-effectiveness of implementing low-tidal volume ventilation in patients with acute lung injury. Chest 136:79-88
23. Gold MR, Franks P, McCoy KI, Fryback DG (1998) Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care 36(6):778-792 (Pubitemid 128454315)
24. Tengs TO, Wallace A (2000) One thousand health-related quality-of-life estimates. Med Care 38(6):583-637
25. van Enckevort PJ, TenVergert EM, Bonsel GJ, Geertsma A, van der Bij W, de Boer WJ, Koopmanschap MA, Al MJ, Rutten FF (1998) Technology assessment of the Dutch Lung Transplantation Program. Int J Technol Assess Health Care 14(2):344-356 (Pubitemid 28237806)
26. Al MJ, Koopmanschap MA, van Enckevort PJ, Geertsma A, van der Bij W, de Boer WJ, TenVergert EM (1998) Cost-effectiveness of lung transplantation in The Netherlands: a scenario analysis. Chest 113(1):124-130 (Pubitemid 28044935)
27. Groen H, van der Bij W, Koeter GH, TenVergert EM (2004) Cost-effectiveness of lung transplantation in relation to type of end-stage pulmonary disease. Am J Transplant 4(7):1155-1162 (Pubitemid 38868608)
28. Blumberg EA, Hauser IA, Stanisic S, Mueller E, Berenson K, Gahlemann CG, Humar A, Jardine AG (2010) Prolonged prophylaxis with valganciclovir is cost effective in reducing posttransplant cytomegalovirus disease within the United States. Transplantation 90(12):1420-1426
29. Morton RL, Howard K,Webster AC, Wong G, Craig JC (2009) The cost-effectiveness of induction immunosuppression in kidney transplantation. Nephrol Dial Transplant 24(7):2258-2269
30. Gordois A, Nobes M, Toohey M, Russ G (2006) Cost-effectiveness of sirolimus therapy with early cyclosporin withdrawal vs. long-term cyclosporin therapy in Australia. Clin Transplant 20(4):526-536 (Pubitemid 43994786)
31. Lee GM, Lebaron C,Murphy TV, Lett S, Schauer S, Lieu TA (2005) Pertussis in adolescents and adults: should we vaccinate? Pediatrics 115(6):1675-1684 (Pubitemid 43843179)
32. Sackett DL, Torrance GW(1978) The utility of different health states as perceived by the general public. J Chron Dis 31(11):697-704
33. Sakai M, Shimbo T, Omata K, Takahashi Y, Satomura K, Kitamura T, Kawamura T, Baba H, Yoshihara M, Itoh H (2008) Cost-effectiveness of gargling for the prevention of upper respiratory tract infections. BMC Health Serv Res 8:258
34. Torrance G, Walker V, Grossman R, Mukherjee J, Vaughan D, La Forge J, Lampron N (1999) Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year. Pharmacoeconomics 16(5 Pt 1):499-520 (Pubitemid 29530153)
35. Grossman R, Mukherjee J, Vaughan D, Eastwood C, Cook R, LaForge J, Lampron N (1998) A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group. Chest 113(1):131-141 (Pubitemid 28044936)
36. Selai C, Rosser R (1995) Eliciting EuroQol descriptive data and utility scale values from inpatients. A feasibility study. Pharmacoeconomics 8(2):147-158
37. Pearson AM, Tosteson AN, Koval KJ, McKee MD, Cantu RV, Bell JE, Vicente M (2010) Is surgery for displaced, midshaft clavicle fractures in adults cost-effective? Results based on a multicenter randomized, controlled trial. J Orthop Trauma 24(7):426-433
38. Grau S, Alvarez-Lerma F, del Castillo A, Neipp R, Rubio-Terres C (2005) Cost-effectiveness analysis of the treatment of ventilator-associated pneumonia with linezolid or vancomycin in Spain. J Chemother 17(2):203-211 (Pubitemid 40732881)
39. Brasel KJ, Borgstrom DC, Weigelt JA (1997) Cost-utility analysis of contaminated appendectomy wounds. J Am Coll Surg 184(1):23-30 (Pubitemid 27010240)
40. Chung KC, Walters MR, Greenfield ML, Chernew ME (1998) Endoscopic versus open carpal tunnel release: a cost-effectiveness analysis. Plast Reconstr Surg 102(4):1089-1099 (Pubitemid 28414635)
41. Jernigan JA, Clemence MA, Stott GA, Titus MG, Alexander CH, Palumbo CM, Farr BM (1995) Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 16(12):686-696 Diseases